Hyalubrix® for TEMPORARY SYNOVIAL FLUID REPLACEMENT reducing pain symptoms and improving joint functionality1

Molecule icon representing hyaluronic acid composition

Composition

Hyaluronic acid sodium salt (30mg/2mL) obtained by bacterial fermentation from a fraction of high molecular weight1

Clinical document icon with clock, representing treatment scheduling

Available Presentation

Box containing 1 pre-filled syringe sealed in a blister1

Stopwatch icon representing treatment duration

Indications

HYALUBRIX® is indicated for the treatment of pain and the improvement of joint functionality in patients affected by degenerative or mechanical arthropathy of the knee, hip, shoulder, ankle and trapeziometacarpal joint1

Syringe icon representing intra-articular injection administration

Dosage & Administration

Cycle of 3 intra-articular injections, at weekly intervals1

Available PRESENTATION

Box containing 1 pre-filled syringe.

Product portfolio

VISCOSUPPLEMENTATION

Medical Devices CE0459.
Read the instructions for use carefully.

References:
1. HYALUBRIX® Patient Information Leaflet

THIS PAGE IS INTENDED ONLY FOR HEALTHCARE PROFESSIONALS

To access this page, please click YES if you are a healthcare professional.
If you are not a healthcare professional, select NO to be redirected.

You are about to leave this website

External content may be subject to different local regulations, product availability may vary by market.